IFPMA-IAPO Webinar: The African Medicines Agency – an important step towards increasing timely availability and access to medicinal products for patients in Africa
On December 8th the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) and the International Alliance of Patient Organisations (IAPO) organised a Webinar that brought together regulators, patients and industry representatives as well as officials from AUDA NEPAD and the WHO to discuss the future of the African Medicines Agency.
About IFPMA
The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) represents over 90 innovative pharmaceutical companies and associations across the globe. Based in Geneva, IFPMA has official relations with the United Nations and contributes industry expertise to help the global health community improve the lives of people everywhere. The industry’s two million employees discover, develop, and deliver medicines and vaccines that advance global health.
Learn more
Related news and resources
Fee system for regional joint assessment procedures in Africa
This joint position paper covers the perspective from industry on the proposed fee system for regional joint assessment procedures in Africa.
Read more
Substandard and falsified medical products (EB152)
On 1 February 2023, IPSF submitted a statement delivered on behalf of IPSF, IAPO, and IFPMA for the WHO EB152 agenda item related to substandard and falsified medical products.
Read moreIncreasing Equitable Access to COVID-19 Vaccines in Africa
This infographic provides an overview of the status of COVID-19 vaccines in Africa, outlining issues of inequitable distribution on the continent, factors contributing to this, and policy recommendations to ensure equitable access to vaccines in future.
Read more